Articles from The Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Petco Health and Wellness Company, Inc. (“Petco” or “the Company”) (NASDAQ: WOOF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Open Lending Corporation (“Open Lending” or “the Company”) (NASDAQ: LPRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novo Nordisk A/S (“Novo Nordisk” or “the Company”) (NYSE: NVO) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Designer Brands Inc. (“Designer Brands” or “the Company”) (NYSE: DBI) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apple Inc. (“Apple” or “the Company”) (NASDAQ: AAPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zeo Energy Corp. (“Zeo” or “the Company”) (NASDAQ: ZEO) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quipt Home Medical Corp. (“Quipt” or “the Company”) (NASDAQ: QIPT) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Petco Health and Wellness Company, Inc. (“Petco” or “the Company”) (NASDAQ: WOOF) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or “the Company”) (NASDAQ: NPCE) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Reddit, Inc. (“Reddit” or “the Company”) (NYSE: RDDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Guild Holdings Company (“Guild” or “the Company”) (NYSE: GHLD) for potential breaches of fiduciary duty on the part of its directors and management.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NET Power Inc. (“Net Power” or “the Company”) (NYSE: NPWR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hallador Energy Company (“Hallador” or “the Company”) (NASDAQ: HNRG) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Caleres, Inc. (“Caleres” or “the Company”) (NYSE: CAL) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sanofi (“Sanofi” or “the Company”) (NASDAQ: SNY) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or “the Company”) (NASDAQ: PTCT) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zenas BioPharma, Inc. (“Zenas” or “the Company”) (NASDAQ: ZBIO) for violations of the federal securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against 3D Systems Corporation (“3D Systems” or “the Company”) (NYSE: DDD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ibotta, Inc. (“Ibotta” or “the Company”) (NYSE: IBTA) for violations of the federal securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Boeing Company (“Boeing” or “the Company”) (NYSE: BA) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reddit, Inc. (“Reddit” or “the Company”) (NYSE: RDDT) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apple Inc. (“Apple” or “the Company”) (NASDAQ: AAPL) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PepGen Inc. (“PepGen” or “the Company”) (NASDAQ: PEPG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vestis Corporation (“Vestis” or “the Company”) (NYSE: VSTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or “the Company”) (NASDAQ: NEOG) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of EchoStar Corporation (“EchoStar” or “the Company”) (NASDAQ: SATS) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or “the Company”) (NASDAQ: ABL) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NWTN Inc. (“NWTN” or “the Company”) (NASDAQ: NWTN) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Brown-Forman Corporation (“Brown-Forman” or “the Company”) (NYSE: BF-A, BF-B) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of KinderCare Learning Companies, Inc. (“KinderCare” or “the Company”) (NYSE: KLC) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Reckitt Benckiser Group plc (“Reckitt” or “the Company”) (OTC: RBGLY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or “the Company”) (NYSE: BLCO) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fortrea Holdings Inc. (“Fortrea” or “the Company”) (NASDAQ: FTRE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Everus Construction Group, Inc. (“Everus” or “the Company”) (NYSE: ECG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. (“Viatris” or “the Company”) (NASDAQ: VTRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Canopy Growth Corporation (“Canopy Growth” or “the Company”) (NASDAQ: CGC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Treace Medical Concepts, Inc. (“Treace” or “the Company”) (NASDAQ: TMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bakkt Holdings, Inc. (“Bakkt” or “the Company”) (NYSE: BKKT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Broadmark Realty Capital Inc. (“Broadmark” or “the Company”) (NYSE: BRMK) for violations of the federal securities laws .

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UroGen Pharma Ltd. (“UroGen” or “the Company”) (NASDAQ: URGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Meta Platforms, Inc. (“Meta” or “the Company”) (NASDAQ: META) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, has filed a class action lawsuit against Red Cat Holdings, Inc. (“Red Cat” or “the Company”) (NASDAQ: RCAT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organon & Co. (“Organon” or “the Company”) (NYSE: OGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADTRAN Holdings, Inc. (“Adtran” or “the Company”) (NASDAQ: ADTN) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Luminar Technologies, Inc. (“Luminar” or “the Company”) (NASDAQ: LAZR) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Flowco Holdings (“Flowco” or “the Company”) (NYSE: FLOC) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultra Clean Holdings, Inc. (“Ultra Clean” or “the Company”) (NASDAQ: UCTT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DoubleVerify Holdings, Inc. (“DoubleVerify” or “the Company”) (NYSE: DV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of OneStream, Inc. (“OneStream” or “the Company”) (NASDAQ: OS) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iovance Biotherapeutics, Inc. (“Iovance” or “the Company”) (NASDAQ: IOVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Strategy Incorporated f/k/a MicroStrategy Incorporated (“Strategy” or “the Company”) (NASDAQ: MSTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Krispy Kreme, Inc. (“Krispy Kreme” or “the Company”) (NASDAQ: DNUT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zynex, Inc. (“Zynex” or “the Company”) (NASDAQ: ZYXI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Krispy Kreme, Inc. (“Krispy Kreme” or “the Company”) (NASDAQ: DNUT) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Senti Biosciences, Inc. (“Senti” or “the Company”) (NASDAQ: SNTI) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metallus Inc. (“Metallus” or “the Company”) (NYSE: MTUS) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cleveland-Cliffs Inc. (“Cleveland-Cliffs” or “the Company”) (NYSE: CLF) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Take-Two Interactive Software, Inc. (“Take-Two” or “the Company”) (NASDAQ: TTWO) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elevance Health, Inc. (“Elevance” or “the Company”) (NYSE: ELV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bitfarms Ltd. (“Bitfarms” or “the Company”) (NASDAQ: BITF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Compass Diversified (“Compass” or “the Company”) (NYSE: CODI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in TaskUs, Inc. (“TaskUs” or “the Company”) (NASDAQ: TASK) for potential breaches of fiduciary duty on the part of its directors and management.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Geron Corporation (“Geron” or “the Company”) (NASDAQ: GERN) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UnitedHealth Group Incorporated (“UnitedHealth” or “the Company”) (NYSE: UNH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Compass Diversified (“Compass” or “the Company”) (NYSE: CODI) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of FTI Consulting, Inc. (“FTI” or “the Company”) (NYSE: FCN) for violations of the securities laws.